Pharmaceutical

Emergent cuts 300 jobs and shuts down two facilities in cost-cutting drive

The operational changes are expected to save the biotech and manufacturing organisation $80m annually.

May 3, 2024 - 00:00
Emergent cuts 300 jobs and shuts down two facilities in cost-cutting drive
The operational changes are expected to save the biotech and manufacturing organisation $80m annually.
Read the original article

Tags:

Previous Article

Biotechs face upward battle with recruiting patients on obesity trials

Next Article

M&A revival with a 71% increase in billion-dollar transactions in Q1 2024

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

MSD’s Keytruda use in adenocarcinoma could be limited based on biomarker

MSD’s Keytruda use in adenocarcinoma could be limited b...

Jun 17, 2023

STAT+: Congress gives doctors Medicare pay bump, sets up December fight in new funding package

STAT+: Congress gives doctors Medicare pay bump, sets u...

Mar 4, 2024

STAT+: Covid-19 burnished pharma’s reputation among patient groups, but access to medicines is now an issue

STAT+: Covid-19 burnished pharma’s reputation among pat...

Apr 29, 2023